COVID-19: AdvaMed Asks USTR To Drop Tariffs On More Chinese Medtech Products
The largest medtech industry group has asked the Office of the US Trade Representative to waive tariffs on more medical devices imported from China as the US fights the COVID-19 crisis. AdvaMed wants an indefinite waiver, or at least one that extends a year beyond when the WHO declares an end to the pandemic.
You may also be interested in...
Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.
Medical countermeasures such as devices and drugs used for COVID-19 could only be purchased from domestic manufacturers under a new executive order.
The Trump administration has decided to waive tariffs on certain medtech products imported from China that could help the US combat the ongoing COVID-19 crisis.